Pradeep J Poonnen

Chemoradiation treatment patterns among United States Veteran Health Administration patients with unresectable stage III non-small cell lung cancer

M. Kelley, B. Seal, K. Lee, 2021, BMC cancer.

Barriers to Prescribing Targeted Therapies for Patients With NSCLC With Highly Actionable Gene Variants in the Veterans Affairs National Precision Oncology Program

J. Snowdon, M. Kelley, G. Jackson, 2021, JCO oncology practice.

Germline Variation in Colorectal Risk Loci Does Not Influence Treatment Effect or Survival in Metastatic Colorectal Cancer

D. Sargent, H. McLeod, R. Goldberg, 2014, PloS one.

Prostate Cancer Screening and the Role of Clinical Practice Guidelines

Pradeep J Poonnen, 2014 .

Medical oncologists’ perspectives of the Veterans Affairs National Precision Oncology Program

J. Snowdon, V. Patel, M. Kelley, 2020, PloS one.

Mutational profiles of head and neck squamous cell carcinomas based upon human papillomavirus status in the Veterans Affairs National Precision Oncology Program

M. Kelley, G. Jackson, E. Katsoulakis, 2022, Journal of Cancer Research and Clinical Oncology.

Polo-like-kinase 1 (PLK-1) and c-myc inhibition with the dual kinase-bromodomain inhibitor volasertib in aggressive lymphomas

T. Phillips, C. Murga-Zamalloa, A. Hristov, 2017, Oncotarget.

Cost-Effectiveness of Tumor Genomic Profiling to Guide First-Line Targeted Therapy Selection in Patients With Metastatic Lung Adenocarcinoma.

D. Voora, M. Kelley, S. Reed, 2021, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Genomic Analysis of Metastatic Solid Tumors in Veterans: Findings From the VHA National Precision Oncology Program.

T. Brettin, M. Kelley, M. Shukla, 2019, JCO precision oncology.